A specialty pharmaceutical company was planning to launch an oral prescription medication for treatment of seizures associated with a rare pediatric disease. The market landscape included several non-pharmacological therapies and non-targeted drugs.
Viscadia was asked to design and build a go-to-market forecasting model for tracking patient journeys and projecting demand on a weekly basis.
Helped the client predict patient journey and product demand for a therapy in a $1B rare diseases market
Conducted detailed stakeholder discussions to understand and define various potential patient journey pathways
Tracked the patient acquisition forecast in the model by incorporating average patient-journey time across different pathways
Assessed therapy-area nuances, patient segments, clinical and commercial drivers of product usage, and estimated both near- and long-term KPIs
Triangulated forecasts against actual weekly data, refined forecast assumptions and facilitated monthly and quarterly forecast updates
Mapped the forecast model back to HCP segments for targeting, creating guidance for sales teams and optimizing patient access efforts
